1. Clinical pharmacology of methotrexate;Bertino;Med. Pediatr. Oncol.,1982
2. Methotrexate: clinical pharmacology, current status and therapeutic guidelines;Bleyer;Cancer Treat. Rev.,1977
3. Chevreau C., Rischman P., Chatelut E., Suc E., Brunner V., Canal P., Bugat R., Relationship between the residual plasma methotrexate levels and toxicity of the combination carboplatin, methotrexate, and vinblastine, Sixth international congress on anti-cancer, Treatment, Paris, p. 103.
4. Relationship between 5-fluorouracile dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU;Gamelin;Cancer,1996
5. Methotrexate pharmacokinetics and prognosis in oseosarcoma;Graf;J. Clin. Oncol.,1994